Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model

Journal of Clinical Investigation

Volumn 107, Issue 6, 2001, Pages 675-683

  Hofmann, Marion A ^a   Lalla, Evanthia ^a   Lu, Yan ^a   Gleason, Michelle Ryu ^a   Wolf, Bonnie M ^a   Tanji, Nozomu ^a   Ferran Jr , Luis J ^a   Kohl, Brigitte ^b   Rao, Vijay ^c   Kisiel, Walter ^d   Stern, David M ^a   Schmidt, Ann Marie ^a  

^a The New York Presbyterian Hospital   (United States)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

^d UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CYANOCOBALAMIN; FOLIC ACID; GELATINASE B; HOMOCYSTEINE; PYRIDOXINE; THROMBOPLASTIN; VASCULAR CELL ADHESION MOLECULE 1;

AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL INJURY; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DISEASE COURSE; HYPERHOMOCYSTEINEMIA; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK FACTOR;

EID: 0035107609     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI10588     Document Type: Article

References (53)

1. Homocyst(e)ine and cardiovascular disease: A critical review of the epidemiologic evidence
2. Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons: The Framingham study
3. Homocystinemia. Vascular injury and arterial thrombosis
4. The oxidant stress of hyperhomocyst(e)inemia
5. Adverse effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen
6. Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst(e)inemia in humans
7. Homocysteine increases cyclin-dependent kinase in aortic rat tissue
8. Homocysteine induces iron catalyzed lipid peroxidation of low density lipoprotein that is prevented by alpha-tocopherol
9. Acute methionine load-induced hyperhomocysteinemia enhances platelet aggregation, thromboxane biosynthesis, and macrophage-derived tissue factor
10. Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator
11. Homocysteine, an atherogenic stimulus, reduces protein C activation by arterial and venous endothelial cells
12. Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine
13. Tissue plasminogen activator binding to the annexin II tail domain. Direct modulation by homocysteine
14. Modulation of annexin II by homocysteine: Implications for atherothrombosis
15. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E
16. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E deficient mice created by homologous recombination in ES cells
17. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes
18. Homocysteine metabolism and risk of myocardial infarction: Relation with vitamins B6, B12 and folate
19. Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts
20. Effect of matrix metalloproteinase inhibition on progression of atherosclerosis and aneurysm in LDL receptor deficient mice overexpressing MMP, MMP-12, and MMP-13 and on restenosis in rats after balloon injury
21. Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation
22. High performance liquid chromatography method for rapid and accurate determination of homocysteine in plasma and serum
23. Antioxidants selectively suppress activation of NF-kappaB by human T cell leukemia virus type 1 Tax protein
24. RAGE mediates a novel proinflammatory axis: A central cell surface receptor for S100/calgranulin polypeptides
25. Response of hyperhomocysteinemia to folic acid supplementation in patients with end-stage renal disease
26. Nuclear factor kappa B: An oxidative stress-responsive transcription factor of eukaryotic cells
27. Inhibition of I kappa B alpha phosphorylation and degradation and subsequent NF-kB activation by glutathione peroxidase overexpression
28. Homocysteine-induced nitric oxide production in vascular smooth-muscle cells by NF-κB-dependent transcriptional activation of Nos2
29. Endothelial nuclear factor kappa B and the initiation of the atherosclerotic lesion
30. VCAM-1 gene transcription and expression are regulated through an oxidant-sensitive mechanism in human vascular endothelial cells
31. Functional analysis of the human VCAM-1 promoter
32. Activation of receptor for advanced glycation endproducts: A mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis
33. Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation endproducts
34. The S100 family of EF-hand calcium-binding proteins: Functions and pathology
35. The S100 protein family: History, function, and expression
36. Atherosclerotic lesions of apolipoprotein E deficient mice contain cells expressing S100 protein
37. Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: A potential mechanism of lesion stabilization
38. Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: Induction of collagenase, stromelysin, and tissue factor
39. Hyperhomocysteinemia is a risk factor of recurrent venous thromboembolism
40. Tissue factor in atherosclerosis
41. Tissue factor in the pathogenesis of atherosclerosis
42. Homocysteine-respondent genes in vascular endothelial cells identified by differential display analysis. GFP78/BiP and novel genes
43. Homocysteine-induced endoplasmic reticulum stress and growth arrest leads to specific changes in gene expression in human vascular endothelial cells
44. Induction of acute translational response genes by homocysteine. Elongation factors-1alpha,-beta, and -delta
45. Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation endproducts blocks hyperpermeability in diabetic rats
46. An alternative view of homocysteine
47. Effects of folate supplementation in hyperhomocysteinemic pigs
48. Treatment of hyperhomocysteinemia with folic acid and vitamins B6 and B12 attenuates thrombin generation
49. Three months supplementation of hyperhomocysteinemic patients with folic acid and vitamin B6 improves biological markers of endothelial dysfunction
50. Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: A randomized, placebo-controlled trial
51. Improved vascular endothelial function after oral B vitamins: An effect mediated through reduced concentrations of free plasma homocysteine
52. Mice deficient in cystathione-β-synthase: Animal models for mild and severe homocyst(e)inemia
53. Endothelial dysfunction in a murine model of mild hyperhomocyst(e)inemia